Advisornet Financial’s Corcept Therapeutics CORT Stock Holding History

Advisornet Financial’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-23	Closed	-$747	–	2130
2023 Q4	$747	Sell	23 -2	-8%	-$55	﹤0.01%	1977
2023 Q3	$681	Buy	25 +4	+19%	+$116	﹤0.01%	1908
2023 Q2	$467	Sell	21 -1	-5%	-$23	﹤0.01%	2070
2023 Q1	$477	Buy	+22	New	+$482	﹤0.01%	2079
2020 Q3	–	Sell	-100	Closed	-$2K	–	1742
2020 Q2	$2K	Buy	+100	New	+$1.41K	﹤0.01%	1577

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Advisornet Financial's CORT Position: Q1 2024 in Review

Advisornet Financial sold out of Corcept Therapeutics (CORT) in Q1 2024, closing a stake of 23 shares — an estimated $747 sold.

Advisornet Financial first reported a position in CORT in Q2 2020 and held it in 5 quarters. The position peaked at $2K in Q2 2020. 287 funds tracked by Wall St. Rank hold CORT as of Q1 2024.

Advisornet Financial reported no remaining Corcept Therapeutics position as of Q1 2024 after selling out during the quarter.
Advisornet Financial sold 23 Corcept Therapeutics shares in Q1 2024, an estimated $747.
Advisornet Financial first reported a position in Corcept Therapeutics in Q2 2020 and held it in 5 quarters.
Advisornet Financial's Corcept Therapeutics position peaked at $2K in Q2 2020.
287 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2024.

Based on Advisornet Financial's 13F filing for Q1 2024, filed 12 Apr 2024.